Drug Design and Discovery in Alzheimer's Disease 2014
DOI: 10.1016/b978-0-12-803959-5.50005-2
|View full text |Cite
|
Sign up to set email alerts
|

Multifunctional Enzyme Inhibition for Neuroprotection - A Focus on MAO, NOS, and AChE Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 264 publications
(298 reference statements)
0
2
0
Order By: Relevance
“…MAO-A inhibitors increase the levels of noradrenaline and serotonin in the brain and are employed to treat anxiety and depression. On the other hand, MAO-B inhibitors are useful for PD symptomatic therapy [8].…”
Section: Introductionmentioning
confidence: 99%
“…MAO-A inhibitors increase the levels of noradrenaline and serotonin in the brain and are employed to treat anxiety and depression. On the other hand, MAO-B inhibitors are useful for PD symptomatic therapy [8].…”
Section: Introductionmentioning
confidence: 99%
“…SP shows various pharmacological properties [ 1 , 7 ], such as anti-inflammatory and antioxidant activity as well as scavenging of reactive oxygen species. Moreover, it has been reported to have beneficial effects in the case of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease [ 7 9 ]. Due to its great potential, an increasing number of research activities have been focused on better investigating the properties of SP.…”
Section: Introductionmentioning
confidence: 99%